Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
Giulio Rossi(University of Modena and Reggio Emilia), Francesco Facchinetti(Inserm)
Cited by 53
Related Papers
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2012|211
Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial Cancer
|Cancer Discovery|2023|69
The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour
|Journal of Clinical Pathology|2005|25
The “Brescia panel” (Claudin‐4 and BRCA‐associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas
|Cancer Cytopathology|2020|24
<em>ROS1</em> rearrangements are uncommon in biliary tract cancers
|Oncology Letters|2020|1